Fig. 1From: 25 years of experience with transjugular intrahepatic portosystemic shunt (TIPS): changes in patient selection and procedural aspectsClinical data by year. a Underlying disease. Share of the three most frequent underlying diseases over the observation period. For a summary of all underlying diseases see appendix. b Comorbidities. The proportion of patients with comorbidities increased over timeBack to article page